(MENAFN- EIN Presswire) EINPresswire/ -- Market Overview

The North American Plastic Surgery market grew from USD 13.0 billion in 2023 to USD 13.8 billion in 2024 and is projected to reach USD 25.8 billion by 2033, expanding at a CAGR of 7.3% during the forecast period from 2025 to 2033. The market is driven by rising aesthetic awareness, technological advances, and increasing demand for minimally invasive procedures.

According to CareCredit, average costs for popular cosmetic surgeries are: facelifts $4,130–$18,866 (avg. $8,584), rhinoplasty $7,350–$9,153, breast augmentation $7,149, liposuction $4,874, tummy tucks $8,205, Brazilian Butt Lifts $8,686, arm lifts $6,732, and thigh lifts $8,715.

Download PDF Brochure:

Browse in-depth TOC on "North American Plastic Surgery Market"
50 – Tables
45 – Figures
180 – Pages

Key Highlights of This Report

1. In 2024, the U.S. maintained a dominant position and emerged as the fastest-growing market within the North American plastic surgery sector.

2. The devices and consumables segment commanded the largest revenue share of 98.5% in 2024, leading the market by type.

3. Among technology types, minimally invasive devices held the largest revenue share at 68.2% in 2024, driving market growth.

Growth Drivers

1. Growing social acceptance and desire for cosmetic enhancement.

2. Technological innovations in laser treatments, injectables, and robotic surgery.

3. Increase in reconstructive surgeries post-trauma and cancer.

4. Expansion of medical tourism and online consultation platforms.

5. Aging population seeking anti-aging and rejuvenation procedures.

Market Segmentation Analysis

By Procedure Type:

Minimally invasive procedures dominate with 60% share (e.g., Botox, fillers, laser therapy).

Surgical procedures include breast augmentation, liposuction, and rhinoplasty.

By End User:

Ambulatory surgical centers and clinics lead adoption, accounting for 65% of procedures.

Hospitals contribute mainly to reconstructive and complex surgeries.

Request for Customized Sample Report as per Your Business Requirement:

Regional Insights

United States:

Largest market segment with USD 6.5 billion in 2024, expected to reach USD 12 billion by 2032. High disposable incomes and well-established healthcare infrastructure support growth.

Canada:

Smaller but growing market with rising adoption of minimally invasive techniques and cosmetic surgery procedures.

Key Players

Key Companies include Allergan Aesthetics (AbbVie) || Galderma S.A. || Johnson & Johnson || Integra Life Sciences || Revance Therapeutics Inc. || Merz || Stryker Corporation || Evolus || Bausch Health (Solta Medical) || InMode || Cynosure || Cutera Inc. || Companies invest heavily in R&D, marketing, and partnerships with dermatologists and plastic surgeons.

Recent Developments

1. FDA approvals for new Facial injectable and laser-based devices.

2. Introduction of AI-based consultation and procedure planning tools.

3. Expansion of hybrid surgical and non-surgical treatment centers.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):

Market Outlook
The North American plastic surgery market is poised for steady growth, supported by technological innovations and increasing consumer acceptance of aesthetic procedures, with minimally invasive treatments leading the way through 2032.

Related Reports

Plastic Surgery Market Growth to $158.7B by 2031 - DataM Intelligence @

Plastic Surgery Instruments Market reaching around USD 8.5 billion by 2031 - DataM Intelligence @

MENAFN18112025003118003196ID1110358425